Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
60135723 | 6013572 | 3 | F | 1994 | 20160824 | 20060328 | 20160824 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-13309745 | BRISTOL MYERS SQUIBB | 38.00 | YR | F | Y | 56.00000 | KG | 20160824 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
60135723 | 6013572 | 1 | PS | SUSTIVA | EFAVIRENZ | 1 | Unknown | UNK | U | 20972 | |||||||||
60135723 | 6013572 | 2 | SS | VIDEX | DIDANOSINE | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 3 | SS | VIDEX | DIDANOSINE | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 4 | SS | ZERIT | STAVUDINE | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 5 | C | ZIDOVUDINE. | ZIDOVUDINE | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 6 | C | ZALCITABINE | ZALCITABINE | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 7 | C | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 8 | C | SAQUINAVIR MESYLATE | SAQUINAVIR MESYLATE | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 9 | C | NEVIRAPINE. | NEVIRAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 10 | C | AMPRENAVIR | AMPRENAVIR | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 11 | C | LOPINAVIR | LOPINAVIR | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 12 | C | RITONAVIR. | RITONAVIR | 1 | Unknown | UNK | U | 0 | |||||||||
60135723 | 6013572 | 13 | C | ACTRAPHANE | INSULIN HUMAN | 1 | Unknown | UNK UNIT, QD | U | 0 | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
60135723 | 6013572 | 1 | HIV infection |
60135723 | 6013572 | 2 | HIV infection |
60135723 | 6013572 | 4 | HIV infection |
60135723 | 6013572 | 5 | HIV infection |
60135723 | 6013572 | 6 | HIV infection |
60135723 | 6013572 | 7 | HIV infection |
60135723 | 6013572 | 8 | HIV infection |
60135723 | 6013572 | 9 | HIV infection |
60135723 | 6013572 | 10 | HIV infection |
60135723 | 6013572 | 11 | HIV infection |
60135723 | 6013572 | 12 | HIV infection |
60135723 | 6013572 | 13 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
60135723 | 6013572 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
60135723 | 6013572 | Abdominal pain upper | |
60135723 | 6013572 | Asthenia | |
60135723 | 6013572 | Caesarean section | |
60135723 | 6013572 | Diabetes mellitus | |
60135723 | 6013572 | Diarrhoea | |
60135723 | 6013572 | Drug ineffective | |
60135723 | 6013572 | Flatulence | |
60135723 | 6013572 | Herpes zoster | |
60135723 | 6013572 | Lipodystrophy acquired | |
60135723 | 6013572 | Live birth | |
60135723 | 6013572 | Myalgia | |
60135723 | 6013572 | Oedema peripheral | |
60135723 | 6013572 | Pancreatitis acute | |
60135723 | 6013572 | Pneumocystis jirovecii pneumonia | |
60135723 | 6013572 | Pregnancy | |
60135723 | 6013572 | Premature delivery | |
60135723 | 6013572 | Pruritus | |
60135723 | 6013572 | Urticaria papular |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
60135723 | 6013572 | 1 | 1999 | 200110 | 0 | |
60135723 | 6013572 | 2 | 1994 | 0 | ||
60135723 | 6013572 | 3 | 1997 | 1999 | 0 | |
60135723 | 6013572 | 4 | 1997 | 1999 | 0 |